Skip To Content
Get Our Newsletter

Support the Forward

Funded by readers like you DonateSubscribe

Jewish researcher shares Nobel Prize in medicine for identifying Hepatitis C virus

(JTA) — The Nobel Prize in medicine was awarded to three scientists who identified the hepatitis C virus.

The prize was awarded Monday to Harvey Alter of the National Institutes of Health, Michael Houghton of the University of Alberta, and Charles Rice of Rockefeller University.

“The Nobel Laureates’ discovery of Hepatitis C virus is a landmark achievement in the ongoing battle against viral diseases. Thanks to their discovery, highly sensitive blood tests for the virus are now available and these have essentially eliminated post-transfusion hepatitis in many parts of the world, greatly improving global health,” the Nobel committee said in announcing the prize.

Alter, 85, who is Jewish, was born in New York and attended medical school at the University of Rochester. Early in his career he worked with the Nobel Prize-winning scientist Baruch Blumberg, who identified the hepatitis B virus.

In 2000, he received the Albert Lasker Award for Clinical Medical Research for his work leading to the discovery of the virus that causes hepatitis C.

Houghton isolated the genetic sequence of the new hepatitis C virus while working at Chiron Corporation in the 1980s. Rice showed that hepatitis C virus alone could cause hepatitis.

The post Jewish researcher shares Nobel Prize in medicine for identifying hepatitis C virus appeared first on Jewish Telegraphic Agency.




Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free under an Attribution-Non Commercial-No Derivatives Creative Commons license as long as you follow our republishing guidelines, which require that you credit Foward and retain our pixel. See our full guidelines for more information.

To republish, copy the HTML, which includes our tracking pixel, all paragraph styles and hyperlinks, the author byline, and credit to Foward. Have questions? Please email us at

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.